MAIA Biotechnology to Present at Two Investor Conferences in April 2024 : vimarsana.com

MAIA Biotechnology to Present at Two Investor Conferences in April 2024

MAIA Biotechnology, Inc., , a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that Chairman and Chief Executive Officer Vlad Vitoc, M.D. will...

Related Keywords

New York , United States , American , , Biotechnology Inc , Chief Executive Officer Vlad Vitoc , New York City , Capital Markets ,

© 2024 Vimarsana